First-in-Class Heart Failure Drug Receives FDA Approval
Meghan Ross, Associate Editor
The FDA today approved sacubitril/valsartan for treating heart failure.
Allison Gilchrist, Associate Editor
Patients with any combination of diabetes, stroke, or myocardial infarction (MI) have a significantly lower life expectancy than those with only 1 of these cardiometabolic conditions.
Krystle Vermes
The FDA is reviewing a once-daily formulation of Pfizer’s tofacitinib citrate (Xeljanz) for rheumatoid arthritis (RA).
Meghan Ross, Associate Editor
Supplementation with omega-3 fatty acids and antioxidants could potentially benefit patients in the very early stages of Alzheimer’s disease.
Rachel Lutz
A virtual clinic launched by 1-800-Pharmacy and the Independent Pharmacy Cooperative aims to assist pharmacists at independent community pharmacies.
Krystle Vermes
Gilead Sciences is seeking FDA approval for its third tenofovir alafenamide-based HIV treatment.
Meghan Ross, Associate Editor
Police say they have caught the man responsible for burning down the Baltimore CVS during the Freddie Gray riots.
Allison Gilchrist, Associate Editor
Moving away from the pay-per-pill standard, Novartis will attempt a new pricing model based on clinical outcomes for its widely anticipated chronic heart failure (HF) drug.

Association News

The Biosimilars Council strongly urges the Department of Health and Human Services and the FDA to avoid any departure from the currently accepted international nonproprietary naming system.
The American Pharmacists Association Foundation will be showcasing the Patient Self-Management Solutions at the Society for Human Resource Management Annual Conference and Exposition.
ASHP approved a policy opposing pharmacists’ participation in capital punishment during the 67th annual session of its House of Delegates last month in Denver.
The American Pharmacists Association announced a call for candidates in the 2016 APhA Board of Trustees and the APhA-Academy of Pharmacy Practice and Management.
An analysis of five pharmacy case studies conducted for the NCPA indicate that the adoption of technology-driven medication synchronization by community pharmacies resulted in improved patient adherence.

Pharmacy Market News

Allergan and Merck announced an agreement under which Allergan will acquire the exclusive rights to Merck’s investigational small molecule oral calcitonin gene-related peptide receptor antagonists.
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Oculeve, today announced that they have entered into an agreement under which Allergan will acquire Oculeve.
The prominent award recognizes the efforts of AkzoNobel and development partners The FReMCo Group and The Gold Standard Foundation.

Strategic Alliance Partner News

SpartanNash store pharmacies will be hosting free DermaView Screenings in July at select locations to help the community assess their risk for skin damage.
Heart Hospital of New Mexico at Lovelace Medical Center has received the Mission: Lifeline Gold Receiving Quality Achievement Award.
Latest Issues